Trifluridine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00432 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 31 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cecum villous adenoma | KG + DL |
| 2 | lipoma of colon | KG + DL |
| 3 | colonic lymphangioma | KG + DL |
| 4 | cecum neuroendocrine tumor G1 | KG + DL |
| 5 | rectosigmoid junction neoplasm | KG + DL |
| 6 | colon leiomyoma | KG + DL |
| 7 | cecal disease | KG + DL |
| 8 | benign neoplasm of cecum | KG + DL |
| 9 | cavernous hemangioma of colon | KG + DL |
| 10 | photosensitivity disease | KG + DL |
| 11 | common wart | KG + DL |
| 12 | colorectal gastrointestinal stromal tumor | KG + DL |
| 13 | colorectal leiomyoma | KG + DL |
| 14 | colon carcinoma in situ | KG + DL |
| 15 | colorectal hamartoma | KG + DL |
| 16 | rectosigmoid carcinoma | KG + DL |
| 17 | colon small cell neuroendocrine carcinoma | KG + DL |
| 18 | sigmoid neoplasm | KG + DL |
| 19 | colorectal lymphoma | KG + DL |
| 20 | appendix cancer | KG + DL |
| 21 | cecum lymphoma | KG + DL |
| 22 | metastatic malignant neoplasm | KG + DL |
| 23 | colon mucosa-associated lymphoid tissue lymphoma | KG + DL |
| 24 | anogenital human papillomavirus infection | KG + DL |
| 25 | Rotor syndrome | KG + DL |
| 26 | gonococcal urethritis | KG + DL |
| 27 | Ureaplasma urethritis | KG + DL |
| 28 | metabolic myopathy due to lactate transporter defect | KG + DL |
| 29 | uterine inflammatory disease | KG + DL |
| 30 | xanthogranulomatous pyelonephritis | KG + DL |
| 31 | urinary tract infection (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.